Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AT-101 with platinum and docetaxel for advanced laryngeal cancer preservation
NCT01633541Phase 2Completed
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Mar 2012
- Primary completion
- Nov 2021
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of r-(-)-gossypol acetic acid in laryngeal cancer, hypopharyngeal cancer, sponsored by University of Michigan Rogel Cancer Center. Started Mar 2012; status: completed.
02
Drugs
r-(-)-gossypol acetic acid
03
Conditions
laryngeal cancerhypopharyngeal cancer
Beyond the preview
Go deeper on NCT01633541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01633541.